Finally, we outline outstanding questions, including the identification of synaptic phospho‐substrates of PTPRD and strategies for modulating its functions across neurodevelopmental, neuropsychiatric, and metabolic disorders. The gene discussed is PTPRD; the disease is metabolic disease.